BioNexus Lab BGLC Risk Reward Ratio BioNexus Gene Lab posts strong revenue net loss How Lufax LU performance compares to expectations Smart Money Outflows 20260507 PIII P3 Health Q4 loss widens dramatically EPS miss hits 138 below estimates despite 146B revenue Why Instil Bio TIL deserves a deeper look right now Smart Money Flows 20260508 MDGL Q1 2026 Earnings NarrowerthanExpected Loss as Rezdiffra Launch Progresses SRFM Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Operations SNDL Q1 2026 Earnings NarrowerThanExpected Loss as Company Navigates Cannabis Market Challenges OLOX Q3 2023 Earnings NarrowerthanExpected Loss Drives 3736 EPS Surprise SOPA Q3 2025 Earnings EPS Falls Far Below Estimates Revenue Not Disclosed VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly